Humedix has launched ELITE 2.0 (Experts Leading Integrated Treatment & Excellence), a restructured KOL program. The kickoff meeting expands and reorganizes the company's previously Elravie filler–centered advisory board (ABM) into a portfolio-wide 'Humedix Clinical Ambassador Council', bringing together eight leading physicians in Korea's aesthetic medicine field. The program is designed around 'HITS (Humedix Integrated Treatment System)' — an initiative that organizes Humedix's core portfolio within a unified integrated-treatment framework, with clinicians building everything from per-product standard guides to site-specific integrated treatment protocols. The first product under study is the ECM booster Elravie Re2O Fine, and chairperson Dr. Hosung Choi of Lieul Seoul Clinic proposed positioning Re2O not through head-to-head comparison but along a separate axis of 'ECM-based tissue reinforcement and regeneration'. Members agreed to pursue a case-based guide centered on patients, indications and combination strategy, together with a candid consensus that captures even the challenging cases; through its regular research sessions, Humedix is setting in motion a roadmap that runs to a consensus book co-authored by the council members and a 'HITS Symposium' in 2027.
#MedicalAestheticNews #Humedix #ELITE2 #LieulSeoulClinic #DrHosungChoi #JFCellDermatology #DrSangyubKim #BeautyBarPlasticSurgery #DrEunyeonKim #OblivClinic #DrYoungjinPark #PleasurePlasticSurgery #DrYooseokShon #FloresDermatology #DrCheonghaWoo #ElevClinic #DrJeongwooLee #LewellClinic #DrHyunheeLee
★ Article Link: https://www.medicalaestheticnews.com/news/articleView.html?idxno=20093

Comments
Post a Comment